NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE:INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Inspire and certain of its officers […]
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Marex Group PLC ("Marex" or the "Company") (NASDAQ:MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Marex and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of The Trade Desk, Inc. ("TTD" or the "Company") (NASDAQ:TTD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether TTD and certain of its officers and/or
The global Oral Rinses Market, valued at US$4.09 billion in 2024, stood at US$4.30 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$5.89 billion by the end of the period. With extensive benefits for dentists and consumers, oral rinses
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of James Hardie Industries plc ("James Hardie" or the "Company") (NYSE:JHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether James Hardie and certain of
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Snap, Inc. ("Snap" or the "Company") (NYSE:SNAP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against PubMatic, Inc. ("PubMatic" or the "Company") (NASDAQ:PUBM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. ("Lineage" or the "Company") (NASDAQ:LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lineage and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ:CAPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Capricor and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation ("Centene" or the "Company") (NYSE:CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged